HPLC column selection: phase, dimensions and column life
Column selection is where a liquid chromatography method is really decided, and it is also where methods quietly break, because two columns described identically by two manufacturers can separate differently. The bonded phase chemistry, the base silica and the end-capping all vary, and the catalogue description conceals most of it. This page covers how to choose and how to protect a method from the column supply.
- the 21 CFR clause requiring complete laboratory records for every test
- 211.194
- the OSHA laboratory standard covering solvent handling and the hygiene plan
- 1910.1450
- the accreditation standard a method validation is judged under
- 17025
Figures in this panel are the rules a separation method is developed, recorded and accredited under, named from the regulations and standards themselves and linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply an instrument index it has not measured.
- 4 vendor service pages verifiedevery figure matched verbatim to the vendor's page
- Quoted and dated, never estimatedlast verification pass 2026-08-24
- 1 service classes coveredeach with measured search demand behind it
Choosing and protecting the column
- Phase from the separation mechanism. Reversed phase covers most small molecule work, with different ligand chemistries offering different selectivity for aromatic, polar and basic analytes. Normal phase, ion exchange and hydrophilic interaction each suit analytes that reversed phase handles poorly. Selectivity, not efficiency, is what usually solves a difficult separation.
- Particle size against system pressure. Smaller particles sharpen peaks and raise back pressure, and the column must match what the system can deliver. Core shell particles offer much of the efficiency of very fine fully porous particles at lower pressure, which is often the practical answer on a conventional system.
- Pore size admits or excludes the analyte. Small molecules suit the standard pore size; peptides and proteins need wider pores or they never reach the internal surface. A method transferred from small molecules to biomolecules without changing pore size is a method that will underperform for reasons that are hard to see.
- Dimensions set loading, solvent and time. Length drives resolution and pressure; diameter drives loading and solvent consumption. Narrower columns save solvent and demand a system with low extra-column volume, otherwise the gains are lost in the tubing and the detector cell.
- Lot reproducibility and a second source. Ask for the manufacturer's lot test chromatogram and acceptance criteria, and for a validated method keep enough of one lot to finish the work. Where a method must live for years, identify a second column that has been shown to work, before you need it.
Making columns last with an HPLC guard column
Guard columns, filtered mobile phase, filtered samples and observing the pH and temperature limits of the phase account for most of the difference between a column that lasts and one that does not. Back pressure trend is the early warning, so record it.
Follow the manufacturer's regeneration protocol rather than improvising a wash. Many phases tolerate a specific sequence and nothing harsher, and an aggressive solvent chosen by analogy kills columns quickly.
Equivalence between HPLC suppliers' columns
Selectivity databases and comparison tools exist to identify columns that behave similarly, and they are far more reliable than matching catalogue descriptions. Even so, an equivalent column has to be demonstrated on your own method before it is adopted.
Record the exact column part number and lot with every method and every dataset. When a separation changes, that record is the first thing anyone will want and the thing most often missing.
An HPLC column equivalent chart describes the chemistry, not the selectivity
Cross-reference tables match columns on stated particle size, pore size, carbon load and endcapping, and those are the properties a manufacturer publishes. Selectivity for your specific separation depends on the silica, the bonding chemistry and the manufacturing process in ways the table cannot express.
So an equivalent column is a candidate for evaluation, never a drop-in replacement in a method that has been validated. Where a method is registered or transferred, the column is part of it and a change has to be justified with data rather than with a table.
Scaling between HPLC column dimensions: calculators are arithmetic, not method development
Scaling calculators convert flow rate, injection volume and gradient time between column dimensions, which is genuinely useful and entirely mechanical. They assume the chemistry is unchanged and that the system's dwell volume is accounted for, and that second assumption is where transfers usually fail.
A gradient method moved between instruments with different dwell volumes will elute differently even with the arithmetic correct. Measure the dwell volume of both systems, include it in the transfer, and re-verify the separation rather than trusting the calculation.
Beyond reversed phase
Reversed phase covers most of what a laboratory separates and fails on very polar compounds, which elute unretained. Polar-embedded and intermediate-polarity bonded phases, aqueous normal phase and mixed-mode supports that combine hydrophobic and ionic retention are the usual answers.
Each brings its own equilibration behaviour and its own sensitivity to buffer and water content, and some require much longer conditioning before retention stabilises. Plan for that in method development rather than concluding a column is faulty on the first injections.
An HPLC column for oligonucleotides, preparative HPLC columns and other demanding analytes
Separating oligonucleotides needs a column and a system that tolerate ion-pairing reagents, a stationary phase that survives the pH used, and temperature control to suppress secondary structure. A general purpose column in a general purpose system will separate them poorly and contaminate the system for everything else.
Ion-pairing reagents are persistent, so laboratories that run these methods keep dedicated columns and often dedicated systems. That commitment is part of the decision to bring the method in house rather than send it out.
Common questions
- How do I choose an HPLC column?
- Start from the separation mechanism the analytes require, then set pore size to admit them, particle size from the pressure your system supports, and dimensions from loading and solvent considerations. Selectivity usually solves difficult separations rather than efficiency.
- Are columns from different manufacturers interchangeable?
- Not reliably. Base silica, bonded phase and end-capping differ even where descriptions match. Use a selectivity comparison tool to shortlist, then demonstrate equivalence on your own method before adopting.
- What are core shell HPLC columns for?
- They deliver much of the efficiency of very fine fully porous particles at lower back pressure, which makes them a practical way to sharpen separations on a conventional pressure system.
- How does a guard column in HPLC make a column last longer?
- Use a guard column, filter mobile phase and samples, stay inside the phase's pH and temperature limits, and follow the manufacturer's regeneration protocol. Track back pressure, which trends upward before a column fails.
- Can I substitute an equivalent column in a validated method?
- Not without data. Equivalence tables match published properties and cannot predict selectivity for your separation. Treat an equivalent as a candidate to evaluate, and where the method is registered, a change has to be justified.
- Why does my gradient method elute differently on another system?
- Usually dwell volume. Systems differ in the volume between the mixer and the column head, which shifts a gradient even when the arithmetic is right. Measure it on both systems and include it in the transfer.
Get a shortlist for your project
Browse by service class
Sources
Cite or embed this figure
The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.
Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/hplc-column/.